Relapsed Hodgkin Lymphoma
4 clinical trials · Condition
◉ Watch Relapsed Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL (NCT06484920) | Rita Assi | 2024-11-18 |
| Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT04052997) | ADC Therapeutics S.A. | 2019-09-13 |
| Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma (NCT04134325) | UNC Lineberger Comprehensive Cancer Center | 2019-09-01 |
| Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma (NCT02875067) | NYU Langone Health | 2016-08-29 |
Track Relapsed Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.